Stock Analysis

Would HYSONIC (KOSDAQ:106080) Be Better Off With Less Debt?

Published
KOSDAQ:A106080

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies HYSONIC Co., Ltd. (KOSDAQ:106080) makes use of debt. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt assists a business until the business has trouble paying it off, either with new capital or with free cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

See our latest analysis for HYSONIC

What Is HYSONIC's Debt?

As you can see below, at the end of March 2024, HYSONIC had ₩10.9b of debt, up from ₩160.8m a year ago. Click the image for more detail. However, it also had ₩5.03b in cash, and so its net debt is ₩5.86b.

KOSDAQ:A106080 Debt to Equity History June 19th 2024

How Strong Is HYSONIC's Balance Sheet?

The latest balance sheet data shows that HYSONIC had liabilities of ₩24.6b due within a year, and liabilities of ₩949.8m falling due after that. On the other hand, it had cash of ₩5.03b and ₩10.7b worth of receivables due within a year. So its liabilities total ₩9.85b more than the combination of its cash and short-term receivables.

Of course, HYSONIC has a market capitalization of ₩72.1b, so these liabilities are probably manageable. Having said that, it's clear that we should continue to monitor its balance sheet, lest it change for the worse. The balance sheet is clearly the area to focus on when you are analysing debt. But it is HYSONIC's earnings that will influence how the balance sheet holds up in the future. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

In the last year HYSONIC had a loss before interest and tax, and actually shrunk its revenue by 33%, to ₩7.0b. That makes us nervous, to say the least.

Caveat Emptor

While HYSONIC's falling revenue is about as heartwarming as a wet blanket, arguably its earnings before interest and tax (EBIT) loss is even less appealing. Indeed, it lost ₩6.2b at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled ₩14b in negative free cash flow over the last twelve months. So in short it's a really risky stock. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For instance, we've identified 4 warning signs for HYSONIC (1 is a bit unpleasant) you should be aware of.

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

Valuation is complex, but we're here to simplify it.

Discover if HYSONIC might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.